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INTRODUCTION: Ambulatory blood pressure monitors have been used in salt loading and depletion protocols.
However, the agreement between measurements made using ambulatory blood pressure monitors and those made
with the sphygmomanometer has not been evaluated.
OBJECTIVE: The objective of this study was to compare the concordance of the two methods of blood pressure
measurements in protocols of acute salt loading and depletion.
METHOD: Systolic blood pressure was measured using a sphygmomanometer at the completion of salt infusion (2 L
NaCl 0.9%, 4 h) and salt depletion (furosemide, 120mg/day, p.o.) in 18 volunteers. Using the Pearson correlation
coefficient (r), these readings were compared with the mean systolic blood pressure measured using the ambulatory
blood pressure monitoring device during the following periods: 4 h of saline infusion and 12 h of salt depletion; 4 h
of saline infusion and the last 6 h of salt depletion; 12 h of salt loading and the last 6 h of depletion; 12 h of salt
loading and 12 h of depletion. Salt sensitivity was defined by a difference in the systolic blood pressure between salt
loading and salt depletion greater than 10 mmHg when measured with the sphygmomanometer, and the Kappa
analysis of concordance (K) was used with a significance level of P,0.05.
RESULTS: Only the blood pressure readings obtained using the ambulatory blood pressure device during 4 h of
intravenous NaCl and during 12 h of salt depletion showed a high correlation with the variation in the systolic blood
pressure measured by the sphygmomanometer, with a full agreement with the salt sensitivity classification (r=0.71;
P = 0.001 and K=1).
CONCLUSION: In acute salt loading and depletion protocols, an ambulatory blood pressure monitoring device
should be used to record the blood pressure during the 4-h interval of salt infusion and 12-h interval of salt
depletion.
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INTRODUCTION
Salt sensitivity (SS) is a heterogeneous phenomenon
characterized by a significant increase in blood pressure
(BP) in response to changes in dietary salt intake or by
experimental intravenous salt overload followed by furose-
mide-induced salt depletion.1 Although multiple mechan-
isms are involved in the BP response to the variation in
sodium intake, an evident change in the renal tubular
transport of sodium occurs in salt-sensitive individuals (S
individuals).2 In salt-resistant individuals (R individuals), a
change from a low-sodium diet (70 mmol/day) to a high-
sodium diet (185 mmol/day) is accompanied by a significant
reduction of sodium reabsorption by the proximal tubules. In
contrast, S individuals experience a significant increase in BP
and a blunted inhibition of proximal tubular sodium
transport. In addition, ‘‘S normotensive individuals’’ respond
to a salt loadwith an increased glomerular filtration rate in an
attempt to compensate for the inability to block the tubular
sodium reabsorption.3 The same response pattern is usually
observed in ‘‘S hypertensive individuals.’’4 Epidemiological
studies have indicated a clear relationship between salt
sensitivity individuals and the development of cardiac
hypertrophy and glomerular damage.5-8 In experimental
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studies with rats, salt loading promotes the expression of
factors related to the deposition of extracellular matrix in the
mesangium, such as TGF-b, independent of changes in BP.9
Moreover, in humans, microalbuminuria is observed in
hypertensive individuals with an S pattern.10,11 The presence
of SS also affects the response to antihypertensive drugs, such
as diuretics and angiotensin-converting enzyme inhibitors.12
Although clinically relevant, the identification of S indivi-
duals involves exaggerated sodium consumption followed
by salt depletion with the use of low-salt diets or diuretics.
Although some authors have indicated better reproducibility
using alternate chronic exposure to low- or high-salt diets,13
the model of acute salt loading and depletion initially
proposed by Weinberger et al.1 is widely accepted for the
identification of S individuals. In this model, volunteers are
subjected to intravenous loading of 2 L of isotonic saline over
a period of 4 h, and at the end of this process, BP is measured
using the conventional sphygmomanometer (CS). On the
next day, the volunteers are subjected to a low-salt diet
(10 mmol/day) followed by three doses of oral furosemide,
and CS BP is again measured at the end of this period. A
difference greater than 10 mmHg between the two periods
indicates the presence of SS. Because of the extensively
documented various factors that interfere with the CS
measurement of BP, some authors have recommended the
use of the ABPMdevice as the best tool for assessing the BP in
acute salt loading and depletion protocols.14 However, there
is no consensus about the ideal time intervals of measure-
ments, and there is no clear evaluation of the agreement
between the twomethods of BP measurement in this context.
Moreover, blood pressure measurements obtained by the
Ambulatory Blood Pressure Monitoring (ABPM) are usually
lower than those obtained using the CS. This could influence
the determination of SS, leading to an incorrect classification.
Thus, the main objective of the present study was to compare
the concordance of two different methods of BP measure-
ments in protocols of acute salt loading and depleting,
including an evaluation of the different time intervals of BP
measurements with the use of an ABPM device.
METHODS
Eighteen healthy, normotensive volunteers aged 18 to 43
years with clinical and biochemical parameters (hepatic,
renal and hematologic function) within normal limits were
selected for the study. The protocol was approved by the
Institutional Research Ethics Committee, and the volunteers
gave written informed consent to participate. The subjects
were instructed to consume a diet containing a standard
amount of sodium (180 mmol/day) five days before the
beginning of the acute protocol. Adherence to the diet was
monitored by the measurement of the 24-h urine sodium on
the fifth standard diet day. On the day of acute protocol,
after an overnight fast, the volunteers were asked to come to
the Clinical Research Unit where they stayed for two days.
Starting at 8:00 am on the first day, 2 L of 0.9% isotonic
saline solution were infused into a peripheral vein over a
period of 4 h. An ABPM device (Spacelabs model 90207,
Washington, USA) was installed in each participant’s non-
dominant arm and programmed to measure BP at 10-
minute intervals for the first 12 h. At the end of the saline
infusion, BP was measured with a previously calibrated
mercury sphygmomanometer, and the mean value of three
measurements was calculated. On the second day of the
experimental period, volunteers consumed a low-salt diet
(10 mmol/day) and received three 40-mg doses of oral
furosemide at 8:00 a.m., 10:00 a.m. and 2:00 p.m. The ABPM
device was again installed according to the parameters
described above, and the CS BP was measured at the end of
salt depletion (8:00 p.m.). The patients were classified as S
individuals when the difference in the CS Systolic BP (SBP)
measurements between the salt loading and salt depletion
periods was .10 mmHg (DSBPdiu-salt). The CS BP measure-
ments were compared to the means obtained using the
ABPM in the following combinations: SBP between the 4 h
of saline infusion and the 12 h of salt depletion (DSBP4-12);
between the 4 h of saline infusion and the last 6 h of salt
depletion (DSBP4-6); between the 12 h of the salt-loading
period and the last 6 h of depletion (DSBP12-6); and between
the 12 h of the salt-loading period and the 12 h of salt
depletion (DSBP12-12). In addition to BP, blood and urine
samples were obtained at the end of the saline infusion
(12:00 p.m. of day 1) and at the end of the protocol (8:00 p.m.
of day 2) for the determination of sodium, creatinine,
plasma renin activity and aldosterone. Sodium and creati-
nine analyses were performed using a standard method.
Plasma renin activity and aldosterone were determined by
radioimmunoassay (DiaSorin, Minnesota, USA). Fractional
sodium excretion (FENa) was determined using the follow-
ing formula: (UNa x Pcr/Ucr x PNa) 6100, where UNa,
PNa, Ucr and Pcr are the concentrations of urine sodium
(mMol), urine creatinine (mg/dL), plasma sodium (mMol)
and plasma creatinine (mg/dL), respectively.
Data were reported as means¡ SEM and were compared
using a paired t-test or ANOVA for repeated measures,
followed by a Bonferroni post-test. The correlations between
FENa and the variation in renin and aldosterone activity
and SBP (CS or ABPM) were determined using the Pearson
correlation, and the concordance between the CS and ABPM
measurements during the various time intervals studied
for the identification of S individuals was determined using
the Kappa (k) coefficient.15 The reference criterion used
for S individual classification was arbitrarily chosen as
DSBPdiu-salt .10 mmHg. The comparison between the
ABPM SBP during the different intervals and the CS SBP
was performed using the Pearson correlation coefficient (r).
The level of significance was set at P,0.05 for all analyses.
SAS/STAT software (Version 9.0, SAS institute, USA) was
used all statistical calculations.
RESULTS
This study included 18 volunteers (10 men and 8 women)
who were self-reportedly white and were on average 29¡2
years old. All of the subjects were normotensive (the SBP and
Diastolic BP (DBP) were 115¡3 mmHg and 73¡2 mmHg,
respectively) and none were obese (BMI of 25.2¡0.9 kg/m2).
The volunteers were divided into S (DSBPdiu-salt.10 mmHg)
and R groups, and their main clinical characteristics are
presented in Table 1. There was no difference between the S
and R groups in nutritional status, age or daily salt
consumption. As expected, the S group showed a greater
reduction of DSBPdiu-salt compared to the R group
(-21.4¡3.0 mmHg vs. -5.0¡1.2 mmHg, P= 0.0006).
However, compared with the use of the CS, we observed a
smaller fall in DSBP in the S group between the salt loading
and depletion periods with use of the ABPM
(-21.4¡3.0 mmHg vs. -12.4¡0.8 mmHg; P= 0.007). Figure 1
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illustrates the behavior of CS BP during the periods of salt
loading and depletion. Salt loading increased the SBP andDBP
(P,0.05) only in the S group. Also, only the S group
experienced a decrease in the SBP and DBP with the
furosemide-induced salt depletion (P,0.05). Figure 1 shows
the behavior of the tubular sodium transport inferred by
FENa. Both R and S volunteers presented elevated FENa
during salt loading (P,0.01) compared with FENa baseline
values. However, only the R group experienced a significant
increase in FENa after furosemide administration when
compared with the salt loading (P,0.05). Table 2 illustrates
that there was no significant difference in the variation of the
response of the renin-angiotensin-aldosterone system between
the R and S groups, as measured in terms of the plasma renin
activity and the plasma aldosterone values between the phases
of salt loading and depletion. Table 2 also shows the behavior
of the excreted sodium load during salt loading and depletion.
A significant increase in the excreted sodium load was
observed after salt loading, which was maintained during
the phase of furosemide use, although there were no
significant differences between the R and S groups.
There was a significant correlation between the SBP and
DBP measurements made using the ABPM and those made
using the CS during the phases of salt loading and depletion
for all the periods analyzed. However, the Pearson correla-
tion coefficient (r) for the different time periods showed
various results; the best correlations were observed between
Table 1 - Clinical characteristics of the volunteers included
in the study protocol. Data are reported as means¡ SEM,
with the number of volunteers in parentheses.
R (11) S (7) P value
Age (years) 28¡2 30¡3 0.85
Women (%) 45% 43% 0.99
BMI (kg/m2) 24¡1 26¡1 0.19
Waist circumference (cm) 87¡3 91¡4 0.32
Office SBP (mmHg) 112¡4 120¡5 0.27
Office DBP (mmHg) 71¡2 74¡3 0.47
Nau 24 h (mEq/L) 140¡17 126¡16 0.85
Creatinine clearance (ml/min) 103¡1 102¡2 0.65
DSBPdiu-salt -5.0¡1.2 -21.4¡3.0 0.0006
DSBP 4-12 -3.9¡1.3 -12.4¡0.8
** 0.0006
**P = 0.007 DSBPdiu-salt vs. DSBP4-12
Figure 1 - CS SBP (A, upper panel left) and DBP (B, upper panel right) during the baseline (B) and periods of salt loading (S) and depletion
(D). Therewas a significant increase in BPwith salt loading (P,0.05) and a decrease in BPwith furosemide-induced salt depletion (P,0.05)
only in the S group. The lower panel shows FENa at baseline (B) and during periods of salt loading (S) and depletion (D) for the R group
(black bars, C) and S group (white bars, D). Data are expressed as means¡ SE; * = P,0.01 vs. baseline; ** P,0.05 S vs. D.
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the CS SBP and the mean of the ABPM SBP measurements
made during the 4 h of intravenous NaCl infusion and the
mean of the ABPM SBP measurements made during the 12 h
of the salt depletion with furosemide (DSBP4-12, r= 0.71).
Figure 2 shows the correlation observed between the CS SBP
and DBP and the mean ABPM BP during the phase of salt
loading (4 h) and depletion with furosemide (12 h).
Table 3 shows the values of concordance (K) for the
classification of S and R using DSBPdiu-salt .10 mmHg as the
reference cut-off value. The same cut-off value was
arbitrarily selected for ABPM. Full concordance (K= 1) with
CS SBP was observed only when the criterion for classifica-
tion was based on the ABPM BP measurements during the 4
to 12-h period (DSBP4-12).
DISCUSSION
The objective of this study was to compare the con-
cordance of two different methods of BP measurement in
protocols of acute salt loading and depletion, including an
Table 2 - Behavior of fractional excretion of sodium (FENa%), urinary sodium excretion (UNa, mMol/h), plasma renin
activity (PRA, ng/ml/h) and plasma aldosterone (pg/mL) during acute sodium loading and depletion. Data are reported
as means ¡ SEM.
R S
Baseline Salt Diuretic Baseline Salt Diuretic
FENa
(%)
0.9¡0.3 2.4¡0.3* 4.2¡0.4*# 1.0¡0.1 3.6¡0.8* 3.0¡0.3*
UNa (mMol/h) 7.5¡0.8 31.5¡3.4* 31.9¡2.6* 8.4¡1.1 46.0¡9.5* 31.1¡5.5*
PRA (ng/mL/h) - 0.9¡0.2 7.2¡2.3# - 0.7¡0.2 5.1¡3.0#
Aldosterone (pg/mL) - 44.8¡7.4 206.4¡27.0# - 70.5¡18.3 236.1¡46.7#
*P,0.05 for the salt and diuretic periods compared with the baseline period; P,0.05 for salt vs. diuretic.
Figure 2 - Pearson correlation coefficients (r) between CS SBP and DBP, with mean BP measured by ABPM during the phase of salt
loading (4 h, upper panel A and B) and of salt depletion with furosemide (12 h, lower panels C and D).
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evaluation of different time intervals of BP measurements
with the use of an ABPM device. Our data showed that the
classification of individuals as S or R, based on the
measurement of the difference in SBP between the periods
of salt loading and depletion using ABPM, varied according
to the time interval of BP measurement. The greatest
concordance between the DSBPdiu-salt using the CS method
defined by Weinberger and an ABPM device to measure BP
was the interval of DSBP 4-12.
The CS DSBPdiu-salt was used here as the ‘‘gold standard’’
because this type of measurement has been extensively
studied in previous protocols1,8 and has been shown to be
correlated with humoral markers, particularly the renin-
angiotensin-aldosterone system. Furthermore, it was shown
to be an independent risk factor for cardiovascular death. In
this context, Weinberg et al. 8 conducted a 27-year follow-up
study of a cohort of 430 normotensive individuals subjected
to the acute salt loading and depletion protocol. They found
that the presence of S individuals detected by this method
was accompanied by an increase in cardiovascular mortality
compared with R individuals.
Previous studies have suggested that the identification of S
individuals can be more accurate by manipulating the sodium
content of an individual’s diet.6,14 However, these protocols rely
on compliance with a specific diet, which results in difficult
technical execution. Another relevant point for the comparison
of these two methodologies is the concordance of the
classification as S individuals and R individuals when the same
volunteer was subjected to the two methods in a sequential
manner. Weinberg et al. reported agreement between acute salt
loading protocols when dietary sodium manipulations were
performed over prolonged periods of time.16 However, other
studies have not had the same results and have reported aweak
concordance between the two methods.14,17
The BP measurement method may also generate an
important bias of the criterion for subject classification as S
individuals and R individuals. However, few studies have
compared the different methods of BP measurement for this
purpose. In a study of dietary salt intervention, the ABPM
measurements were more accurate than the use of office BP
measurement for the classification of S individuals and R
individuals an observation that was suggested to be due to
the larger number of measurements obtained with the
ABPM, which may have involved a lower chance of error.13
The present study contributes to the definition of the best
time interval for BP measurements when using the ABPM
device in protocols of acute salt loading and salt depletion.
Our data show that the time interval of BPmeasurements had
a clear influence on the designation of S and R individuals,
with the CS BP used as the standard. Analysis of the Pearson
coefficient (Table 2) showed that the measurements made
between the periods of 4 and 12 h, which corresponded to the
peak of salt load (during the 4 h of intravenous NaCl
infusion) of the first day, and the measurements obtained
during the daytime of the second day were best correlated
with the variation of CS SBP between the two periods.1 The
same table also shows a poor correlation between the SBP
measurements corresponding to 12 h of daytime salt loading
and those corresponding to 12 h of daytime salt depletion,
particularly thosemost frequently used in this protocol.18 The
analysis of concordance (K) supported the Pearson univariate
analysis, showing full agreement between the measurements
of DSBP4-12 and D SBPdiu-salt. Despite this agreement, there
was a significant difference in the DSBP values obtained by
the twomethods, with greater amplitude and dispersal of the
CS measurements compared with the ABPM measurements.
The results of this study do have limitations because the
sample size was small (18 individuals). Also, the DSBP value
.10 mmHg was arbitrarily established for the classification
of S. However, the ABPM BP measurements were usually
lower values than those obtained with the CS, an observation
that may modify the cut-off for the classification of S
individuals on the basis of ABPM. Because the variation in
SBP between the phases of salt loading and depletion follows
a Gaussian distribution, a new study with a larger number of
participants is necessary to determine the best ABPM cut-off
value to distinguish R and S individuals. However, such
limitations do not invalidate the observation that the best
interval for measuring BP with the ABPM is DSBP4-12.
In conclusion, the present study shows that the use of
ABPM in protocols of acute salt loading and depletion
should involve measurements at 10-minute intervals, with a
recording of the 4-h interval of acute intravenous salt
infusion and the 12-h interval of salt depletion with
furosemide and setting the cut-off value for the classifica-
tion of S at DSBP4-12 .10 mmHg.
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